Previous studies have shown that a direct renin inhibitor increased pancreatic islet function and upregulated insulin action on skeletal muscle glucose transport, further improving glucose intolerance and insulin resistance through the downregulation of tissue Ang II and Ang II type 1 receptor [33, 34]. The gene discussed is REN; the disease is Insulin resistance.